I discuss my thoughts of Momentus Space in their niche in the upcoming future of space.

Preecludia | Fraud or not? This article dives into the legitimacy of Progenity's product

OPEN INVITATION - Details below - Every Wednesday Note: This itinerary will be updated. I will start the call discuss some of my thoughts...

Tech Pills chances of success and legitimacy Deep diving into LED light detection and Fed vs Fasted upcoming studies

OPEN INVITATION - Details below - Every Wednesday Note: This itinerary will be updated. I will start the call discuss some of my thoughts...

This shows the analysis of the future revenue of Progenity and future share price

OPEN INVITATION - Details below - Every Wednesday Note: This itinerary will be updated. I will start the call discuss some of my thoughts...

Description of the studies for you knowledge and how it will effect share price upon release of results

OPEN INVITATION - Details below - Every Wednesday Note: This itinerary will be updated. I will start the call discuss some of my thoughts...

Data is around the corner, details on what to look for and what to expect. Why this pill tech will disrupt healthcare

We will speak about Progenity and their upcoming events & technology that is dominant against competition

Research and help to understand what this company is and why investors piled in before it fell. Is CEI a good investment?

Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...

Itinerary and landing page to discussion of Progenity every wednesday evening at 7pm central time. Audio recording is uploaded afterwards

The future timeline for the adoption of Progenity's products. S-curve uptrend starts this December.

Itinerary for upcoming Twitter Spaces call

Clarification on the product lines for Progenity and near term catalysts in the future.

Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...

Progenity to dominate the market during end of year. Price appreciation is on the horizon due to market reevaluation and catalysts ahead.

Competition of Progenity. Shows the top competitors and how Progenity is the leader, however, is extremely undervalued and overshadowed